摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-benzyl-7-phenyl-2,3-dihydro-1H-imidazo[1,2-a]pyridin-5-one | 66066-11-3

中文名称
——
中文别名
——
英文名称
1-benzyl-7-phenyl-2,3-dihydro-1H-imidazo[1,2-a]pyridin-5-one
英文别名
1-Benzyl-5-oxo-7-phenyl-1,2,3,5-tetrahydroimidazo[1,2-a]pyridine;1-benzyl-7-phenyl-2,3-dihydroimidazo[1,2-a]pyridin-5-one
1-benzyl-7-phenyl-2,3-dihydro-1<i>H</i>-imidazo[1,2-<i>a</i>]pyridin-5-one化学式
CAS
66066-11-3
化学式
C20H18N2O
mdl
——
分子量
302.376
InChiKey
FQPPXPMBJAKCCQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    23
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.15
  • 拓扑面积:
    23.6
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为产物:
    描述:
    6-chloro-1-(4-chloro-phenyl)-4-phenyl-1H-pyridin-2-oneN-苄基乙二胺乙二醇乙醚 反应 50.0h, 以obtained as in Example 5, 0.5 g的产率得到1-benzyl-7-phenyl-2,3-dihydro-1H-imidazo[1,2-a]pyridin-5-one
    参考文献:
    名称:
    Nitrogen-containing heterocyclic ring derivatives and analgesic and
    摘要:
    以下是化学式:##STR1## 其中R.sub.1和R.sub.2中的一个表示较低的烷基,苯基,卤苯基或较低的烷氧基苯基,另一个表示氢原子,较低的烷基或苯较低的烷基;R.sub.1和R.sub.2可以结合形成三亚甲基基团或四亚甲基基团;R.sub.3表示氢原子,较低的烷基,苯基或苯较低的烷基;X表示氧原子,硫原子,亚胺基或由##STR2##(其中m表示1或2,R.sub.4表示较低的烷基,羟基较低的烷基,环烷基或苯较低的烷基)表示的基团;Y表示乙烯基,可以通过较低的烷基,三亚甲基基团,四亚甲基基团,可以通过较低的烷基取代的乙烯基,或##STR3##(其中R.sub.5表示氢原子,较低的烷基,三氟甲基基团或苯基);当R.sub.1和R.sub.2中的一个是较低的烷基而另一个是氢原子时,X是由##STR4##表示的基团,Y是乙烯基,以及其药理学上可接受的无毒盐。上述化合物是强的镇痛抗炎剂。
    公开号:
    US04288438A1
点击查看最新优质反应信息

文献信息

  • Novel fused derivatives of 2-pyridones
    申请人:Yamanouchi Pharmaceutical Co., Ltd.
    公开号:US04186200A1
    公开(公告)日:1980-01-29
    Novel nitrogen-containing heterocyclic compounds shown by the formula ##STR1## wherein one of R.sub.1 and R.sub.2 represents a lower alkyl group, a phenyl group, a halophenyl group, or a lower alkoxyphenyl group and the other of them represents a hydrogen atom, a lower alkyl group, or a phenyl lower alkyl group; said R.sub.1 and R.sub.2 may combine with each other to form a trimethylene group or a tetramethylene group; R.sub.3 represents a hydrogen atom, a lower alkyl group, a phenyl group, or a phenyl lower alkyl group; X represents an oxygen atom, a sulfur atom, an imino group, or a group shown by ##STR2## wherein m represents 1 or 2 and R.sub.4 represents a lower alkyl group, a hydroxy lower alkyl group, a cycloalkyl group or a phenyl lower alkyl group; and Y represents an ethylene group which may be substituted by lower alkyl group, a trimethylene group, a tetramethylene group, a vinylene group which may be substituted by a lower alkyl group, or ##STR3## wherein R.sub.5 represents a hydrogen atom, a lower alkyl group, a trifluoromethyl group, or a phenyl group; said X is the group shown by ##STR4## when one of said R.sub.1 and R.sub.2 is a lower alkyl group and the other is a hydrogen atom, and said Y is an ethylene group, and the pharmacologically acceptable non-toxic salts thereof. The compounds described above are strong analgesic anti-inflammatory agents.
    该文描述了一种新型含氮杂环化合物,其化学式为 ##STR1## 其中R.sub.1和R.sub.2中的一个代表低碳基,苯基,卤代苯基或低碳基苯基,另一个代表氢原子,低碳基或苯基低碳基;R.sub.1和R.sub.2可以结合形成三亚甲基基团或四亚甲基基团;R.sub.3代表氢原子,低碳基,苯基或苯基低碳基;X代表氧原子,原子,亚胺基或由##STR2## 所示的基团,其中m代表1或2,R.sub.4代表低碳基,羟基低碳基,环烷基或苯基低碳基;Y代表乙烯基,可以被低碳基取代,三亚甲基基团,四亚甲基基团,可以被低碳基取代的乙烯基,或者##STR3## 其中R.sub.5代表氢原子,低碳基,三甲基基团或苯基;当R.sub.1和R.sub.2中的一个是低碳基,另一个是氢原子时,X是##STR4## ,Y是乙烯基,并且其药学上可接受的无毒盐。上述化合物是强烈的镇痛抗炎药物。
  • Nitrogen-containing heterocyclic compounds
    申请人:Yamanouchi Pharmaceutical Co., Ltd.
    公开号:US04251533A1
    公开(公告)日:1981-02-17
    Novel nitrogen-containing heterocyclic compounds shown by the formula ##STR1## wherein one of R.sub.1 and R.sub.2 represents a lower alkyl group, a phenyl group, a halophenyl group, or a lower alkoxyphenyl group and the other of them represents a hydrogen atom, a lower alkyl group, or a phenyl lower alkyl group; said R.sub.1 and R.sub.2 may combine with each other to form a trimethylene group or a tetramethylene group; R.sub.3 represents a hydrogen atom, a lower alkyl group, a phenyl group, or a phenyl lower alkyl group; X represents an oxygen atom, a sulfur atom, an imino group, or a group shown by ##STR2## wherein m represents 1 or 2 and R.sub.4 represents a lower alkyl group, a hydroxy lower alkyl group, a cycloalkyl group or a phenyl lower alkyl group; and Y represents an ethylene group which may be substituted by lower alkyl group, a trimethylene group, a tetramethylene group, a vinylene group which may be substituted by a lower alkyl group, or ##STR3## wherein R.sub.5 represents a hydrogen atom, a lower alkyl group, a trifluoromethyl group, or a phenyl group; said X is the group shown by ##STR4## when one of said R.sub.1 and R.sub.2 is a lower alkyl group and the other is a hydrogen atom, and said Y is an ethylene group, 1/7 and the pharmacologically acceptable non-toxic salts thereof. The compounds described above are strong analgesic anti-inflammatory agents.
    以下是翻译结果: 新颖的含氮杂环化合物,其化学式为##STR1##其中R.sub.1和R.sub.2中的一个代表低碳基,苯基,卤代苯基或低烷氧基苯基,另一个代表氢原子,低碳基或苯基低碳基;R.sub.1和R.sub.2可以结合形成三亚甲基基团或四亚甲基基团;R.sub.3代表氢原子,低碳基,苯基或苯基低碳基;X代表氧原子,原子,亚基团或由##STR2##所示的基团,其中m代表1或2,R.sub.4代表低碳基,羟基低碳基,环烷基或苯基低碳基;Y代表乙烯基,可以被低碳基取代,三亚甲基基团,四亚甲基基团,可以被低碳基取代的乙烯基,或##STR3##其中R.sub.5代表氢原子,低碳基,三甲基基团或苯基;当R.sub.1和R.sub.2中的一个是低碳基而另一个是氢原子时,X是由##STR4##所示的基团,Y是乙烯基,1/7和药理学上可接受的非毒性盐。上述化合物是强烈的镇痛抗炎剂。
  • Nitrogen-containing heterocyclic ring derivatives
    申请人:Yamanouchi Pharmaceutical Co., Ltd.
    公开号:US04284778A1
    公开(公告)日:1981-08-18
    Novel nitrogen-containing heterocyclic compounds shown by the formula ##STR1## wherein one of R.sub.1 and R.sub.2 represents a lower alkyl group, a phenyl group, a halophenyl group, or a lower alkoxyphenyl group and the other of them represents a hydrogen atom, a lower alkyl group, or a phenyl lower alkyl group; said R.sub.1 and R.sub.2 may combine with each other to form a trimethylene group or a tetramethylene group; R.sub.3 represents a hydrogen atom, a lower alkyl group, a phenyl group, or a phenyl lower alkyl group; X represents an oxygen atom, a sulfur atom, an imino group, or a group shown by ##STR2## wherein m represents 1 or 2 and R.sub.4 represents a lower alkyl group, a hydroxy lower alkyl group, a cycloalkyl group or a phenyl lower alkyl group; and Y represents an ethylene group which may be substituted by a lower alkyl group, a trimethylene group, a tetramethylene group, a vinylene group which may be substituted by lower alkyl group, or ##STR3## wherein R.sub.5 represents a hydrogen atom, a lower alkyl group, a trifluoromethyl group, or a phenyl group; said X is the group shown by ##STR4## when one of said R.sub.1 and R.sub.2 is a lower alkyl group and the other is a hydrogen atom, and said Y is an ethylene group, and the pharmacologically acceptable non-toxic salts thereof. The compound described above are strong analgesic anti-inflammatory agents.
    这是一种新型含氮杂环化合物,其化学式为##STR1##其中R.sub.1和R.sub.2中的一个代表较低的烷基、苯基、卤代苯基或较低的烷氧基苯基,另一个代表氢原子、较低的烷基或苯基较低烷基;R.sub.1和R.sub.2可以结合形成三亚甲基基团或四亚甲基基团;R.sub.3代表氢原子、较低的烷基、苯基或苯基较低烷基;X代表氧原子、原子、亚胺基或由##STR2##所示的基团,其中m代表1或2,R.sub.4代表较低的烷基、羟基较低烷基、环烷基或苯基较低烷基;Y代表乙烯基,可以被较低的烷基、三亚甲基基团、四亚甲基基团、可以被较低烷基取代的乙烯基或由##STR3##所示的基团取代;R.sub.5代表氢原子、较低的烷基、三甲基基团或苯基;当R.sub.1和R.sub.2中的一个是较低的烷基,另一个是氢原子时,X是由##STR4##所示的基团,Y是乙烯基,且其药理学上可接受的无毒盐。上述化合物是强的镇痛和抗炎药物。
  • US4186200A
    申请人:——
    公开号:US4186200A
    公开(公告)日:1980-01-29
  • US4251533A
    申请人:——
    公开号:US4251533A
    公开(公告)日:1981-02-17
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫